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OBJECTIVES OF THE MEETING 
Group B Streptococcus is estimated to colonize 10% to 20% of pregnant women. Infection with GBS 
is considered an important public health issue, since it is associated with neonatal sepsis, death, 
chorioamnionitis, perinatal infection and preterm labour. The majority of infections are associated 
with intrapartum transmission of the microorganisms and therefore since a few years, several 
societies following the CDC recommendations have applied the strategy of GBS universal screening of 
pregnant women in the last month of pregnancy associated with the use of prophylactic antibiotics 
during labour. Although this strategy has led to a significant reduction in early onset neonatal GBS 
disease, there is, as a counterpart, an abuse of antibiotics during intrapartum, an increase risk of 
antimicrobial resistance and an increased number of unwanted side effects of antibiotics. Moreover, 
different sampling techniques and different culture methods for the GBS carriage in pregnant women 
may bring to an increase in the number of false positive and false negative results, taking also into 
consideration that the microbiological test performed far from labour does not accurately predict the 
GBS colonization of the genital tract, because GBS may be transient or intermittent and re-
colonization can occur after the time of screening. Moreover, almost three quarters of full term 
infants with early onset disease is born to mothers screened antenatally and found culture-negative. 
Furthermore, some important societies like RCOG have recently published new guidelines which do 
not support anymore the prepartum screening. Therefore, actually there is a need to reach a 
consensus to try to overcome all these limitations and to homogenize the current practices and 
strategies in the European countries, in order to detect quickly and accurately the real GBS status at 
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